Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases

Artikel in diesem Heft

1. Natriuretic peptides and evidence-based quality specifications
2. Preanalytical variability: the dark side of the moon in laboratory testing
3. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
4. Hepatorenal syndrome
5. Modified Levey-Jennings charts for calculated laboratory tests
6. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
7. The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
8. Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest^® and Actitest^® scores
9. Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
10. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
11. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
12. Erythrocyte membrane Na⁺,K⁺-ATPase and Mg²⁺-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
13. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
14. Pyrosequencing protocol requiring a unique biotinylated primer
15. Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
16. Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
17. Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
18. Stepwise strategies in analysing haematuria and leukocyturia in screening
19. Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
20. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
21. Release of anandamide from blood cells
22. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
23. Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
24. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
25. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
26. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
27. The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
28. Is cystatin C a reliable renal marker in trauma?
29. On the independence of intraindividual reference values
30. Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006